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Belinda Y. Betsch,1 Stefan Eggli,2 Klaus A. Siebenrock,2 Martin G. Ta¨uber,1,3 and Kathrin Mu¨hlemann1,3
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Background. Recently recommended treatment modalities for prosthetic joint infection (PJI) were evaluated.
Methods. A retrospective cohort analysis of 68 patients with PJI of hip or knee who were treated from 1995
through 2004 was conducted at the University Hospital Bern (Bern, Switzerland).
Results. A 2-stage exchange was the most frequent (75.0%) surgical strategy, followed by retention and de-
bridement (17.6%), 1-stage exchange (5.9%), and resection arthroplasty or suppressive antimicrobial treatment
(1.5%). The chosen strategy was in 88% agreement with the recommendations. Adherence was only 17% for
retention and debridement and was 0% for 1-stage exchange. Most PJIs (84%) were treated with an adequate or
partially adequate antimicrobial regimen. Recurrence-free survival was observed in 51.5% of PJI episodes after 24
months of follow-up. The risk of treatment failure was significantl higher for PJI treated with a surgical strategy
other than that recommended (hazard ratio, 2.34; 95% confidenc interval, 1.10–4.70; ) and for PJIs treatedPp .01
with antibiotics not corresponding to recommendations (hazard ratio, 3.45; confidenc interval, 1.50–7.60; Pp
). Other risk factors associated with lack of healing were a high infection score at the time of diagnosis (hazard.002
ratio, 1.29; 95% confidenc interval, 1.10–1.40; ) and presence of a sinus tract (hazard ratio, 2.35; 95%P ! .001
confidenc interval, 1.10–5.0; ).Pp .02
Conclusions. Our study demonstrates the value of current treatment recommendations. Inappropriate choice
of conservative surgical strategies (such as debridement and retention) and inadequate antibiotic treatment are
associated with failure.
Prosthetic joint infection (PJI) is a severe complication,
causing significan morbidity and health care costs [1–
3]. Much progress has been made in the prevention
and management of PJI [4, 5]. Nevertheless, absolute
numbers of PJIs are increasing because of a rise in the
number of trauma and older patients requiring joint
replacement [6]. Treatment of PJI includes surgical in-
tervention(s) and antimicrobial therapy. Curative sur-
gical strategies vary in their invasiveness from debri-
dement and retention of the infected prosthesis to
2-stage exchange with or without the placement of a
spacer or an extension device. Factors to be considered
for the choice of the appropriate treatment modality
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are the conditions of the bone and soft tissue, the vir-
ulence and antimicrobial susceptibility of the pathogen,
the general health status of the patient, and the expe-
rience of the surgeon [4]. To date, only 1 randomized
study for the treatment of infection associated with
orthopedic devices has been conducted [7]. This study
was restricted to PJI and internal fixatio devices with
short duration of symptoms, caused by Staphylococcus
aureus, and amenable to an oral regimen of rifampicin
and ciprofloxacin Recently, treatment recommenda-
tions have been published that cover a much broader
spectrum of PJI [3]. The rationale of these guidelines
was based on data from experimental and clinical stud-
ies, including animal experiments, case series, and the
1 randomized trial mentioned above [7]. Also, 2 pro-
spective surveillance studies showed high success rates
for PJIs treated in accordance with the suggested al-
gorithm [8, 9]. However, these 2 studies were per-
formed in the same center, and a relatively high pro-
portion of PJIs was treated with debridement and
retention or a 1-stage replacement strategy indicative
of less severe PJI with lower risk of treatment failure.
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Table 1. Definitions of terms for a study of prosthetic joint infection (PJI).
Term Definition
PJIa Presence of a sinus tract communicating with the joint space or a positive bacterial culture result for at
least 2 intraoperative tissue specimens or a joint aspirate specimen or the presence of neutrophils in
tissue specimens or intraoperative purulence
Timing of PJI Relative to prosthesis implantation: (1) early, !3 months; (2) delayed, 3–24 months; (3) late, 124 months
Long-term PJI Duration of symptoms 3 weeks before diagnosis
Episode of PJI Beginning with diagnosis of PJI at study center and ending at end of the follow-up time or treatment
failure
Infection score According to Zimmerli et al. [11], with the following adaptations (maximal score, 17): (1) a maximum of
1 point each for local redness and warmth and (2) no score for local induration
Comorbidity Charlson Comorbidity Index [12]
Immunosuppression (1) Steroid therapy (20 mg of prednisone per day) during the 2 months before PJI onset, (2) chemo-
therapy or radiotherapy, (3) neoplastic disease, and (4) connective-tissue disease
Surgical strategy (1) Debridement and device retention, (2) 1-stage exchange with removal of the infected prosthesis and
reimplantation of a new prosthesis in the same procedure, (3) 2-stage exchange (interval between
resection and reimplantation), (4) palliative (long-term suppressive oral antimicrobial therapy or perma-
nent explantation or joint arthrodesis [girdlestone]) [3]
Antimicrobial treatment category (1) Adequate (total duration of 3 months, duration of therapy administered intravenously 2 weeks,
use of agent-appropriate drugs according to susceptibility testing and clinical studies, use of antibiot-
ics with efficacy against surface-adhering bacteria, if possible), (2) partially adequate (duration of at
least 2 but !3 months and/or !2 weeks of therapy administered intravenously), (3) inadequate (anti-
microbial treatment not corresponding to the above or no antimicrobial treatment) [8]
Healing Absence of clinical and radiological and, if applicable, intraoperative signs and symptoms of PJI and
sterile culture samples from intraoperative specimens obtained at reimplantation of the prosthesis or
any other surgical procedure involving the joint during the 24-month follow-up time; “probable heal-
ing” was defined as above, but with a follow-up period of close to 2 years (20-24 months) [8]
a Based on the definition of Berbari et al. [10].
The applicability of this algorithm to other patient populations
remains to be evaluated.
The aim of the present study was to evaluate the external
clinical validity of this treatment recommendation and to an-
alyze risk factors for treatment failure in a retrospective cohort
study of 68 consecutive episodes of PJI.
METHODS
Study setting. The University Hospital of Bern (Bern, Swit-
zerland) is an ∼1000-bed tertiary care center with 130,000 ad-
missions per year. The referral area covers the local region, with
a population of ∼1 million inhabitants, and includes a large
number of smaller hospitals within and outside the Bernese
region. The Clinic for Orthopedic Surgery performs ∼140 hip
and ∼80 knee prosthesis implantations per year. Written per-
ioperative infection control guidelines are employed. The op-
erating theater has laminar flo ventilation, and cefuroxime is
used routinely for perioperative prophylaxis. The clinic serves
as the local reference center for difficult-to-t eat orthopedic
conditions, including PJI. During the evaluation period, the
choice of the treatment strategy for PJI was at the discretion
of the surgeon, with or without consultation with the infectious
diseases team.
Study design and study population. The study was per-
formed according to local ethical guidelines. In a retrospective
cohort design, all patients who underwent a hip or total knee
arthroplasty and who received a diagnosis of PJI at our Or-
thopedic Clinic from 1 January 1995 through 31 December
2004 were included.
Study patients were identifie using the clinic’s patient in-
formation system. Microbiological data were retrieved from the
laboratory information system of the Institute for Infectious
Diseases, University of Bern (Bern, Switzerland). Socioeco-
nomic characteristics and clinical patients’ data were collected
from the clinical charts through use of a standardized ques-
tionnaire. The terms and definition that were used are pre-
sented in table 1.
Statistical analysis. All analyses were performed with
StatView, version 5.0 (SAS Institute). Differences between
means were tested by Student’s t test or the Mann-Whitney U
test, and proportions were compared using the x2 test or
Fisher’s exact test, as appropriate. The probability of prosthesis
survival within 24 months after implantation was estimated
using the Kaplan-Meier survival method. Risk factors for treat-
ment outcome identifie by univariate statistics were entered
into a Cox regression model. The fina model contained the
largest number of variables with . A 2-tailed P valueP .05
.05 was used as the cutoff value for all statistical analyses.
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Table 2. Sociodemographic characteristics and clinical history
of patients with prosthetic joint infection.
Variable
Patients
(n p 68)
All infection episodes 68 (100)
Age, mean years  SD 67.1  11.7
Male sex 47 (69.1)
Prosthesis implantation sitea
Study center 14 (20.6)
External center 49 (72.1)
Unknown 5 (7.4)
Duration of symptomsb
!3 weeks 29 (42.6)
3 weeks 37 (54.4)
Unknown 2 (3.0)
Type of infection
Early 6 (8.8)
Delayed 30 (44.1)
Late 32 (47.1)
Treatment of PJI 14 days before referral 28 (41.2)
Sinus tract 14 (20.6)
Infection score, mean score  SD 8.1  3.0
Surgical strategy
Retention and debridement 12 (17.6)
1-Stage exchange 4 (5.9)
2-Stage exchange 51 (75.0)
Suppressive antimicrobial treatment 1 (1.5)
NOTE. Data are no. (%) of patients, unless otherwise indicated.
a Information on implantation site was lacking in 10 episodes.
b In 2 episodes, duration of symptoms was unknown.
Table 3. Microbiological characteristics of 68 episodes of pros-
thetic joint infection.
Microbiological characteristic
No. (%)
of episodes
(n p 68)
Single microorganisma 52 (76.5)
Staphylococcus aureus 26 (38.2)
Coagulase-negative staphylococci 9 (13.2)
Streptococcus species 11 (16.2)
Enterococcus species 2 (2.9)
Gram-negative rods 2 (2.9)
Anaerobes 1 (1.5)
Propioni species 1 (1.5)
Polymicrobial 15 (22.0)
Microorganism unknown 1 (1.5)
a Methicillin resistance was observed in 1 isolate of S. aureus and in 13 of
19 isolates of coagulase-negative staphylococci (including isolates from po-
lymicrobial infections).
RESULTS
Demographic and clinical characteristics. This retrospective
study identifie a total of 68 PJI episodes in 68 patients treated
at our center from 1996 through 2004 (table 2). Most PJIs (60
PJIs; 88%) affected hip prostheses. The mean of pa-age SE
tients was years, the patients were predominantly male67 12
(47 men; 67.6%) and had a of comor-mean SE 1–2 1.6
bidities. The incidence of drug abuse (in 1 patient; 1.4%) and
immunosuppression (among 6 patients; 8.8%) was low. In 14
(20.6%) of the episodes, the prosthesis was implanted at our
center. Therefore, the surgical infection rate was 1.2% (for 60
patients) for hip and 0.4% (for 8 patients) for knee prosthesis
implants during the 10-year study period.
In 28 episodes (41%), the PJI had been treated for 114 days
at another institution before referral to our center; the duration
of previous treatment was !3 months in 7 (25%) of these
episodes and was 3 months in the remaining 21 (75%) ep-
isodes. The mean infection at the time of PJI di-score SE
agnosis was points (table 2).8 3
Microbiology. Sixty-seven of the 68 PJIs were microbio-
logically confi med. In 52 episodes (76%), culture revealed a
single microorganism. S. aureus was the most common path-
ogen, followed by a polymicrobial flora streptococci, and co-
agulase-negative staphylococci (table 3). In all polymicrobial
episodes, staphylococci were involved. In 4 of the 15 episodes
of polymicrobial PJI, there was a sinus tract.
Treatment strategy. A 2-stage exchange was the most com-
monly (51 episodes; 75%) pursued surgical strategy (table 2);
the 2-stage strategy was in 88% (44 of 51 episodes) agreement
with the recommendations by Zimmerli et al. [3]. Adherence
was lower for the less invasive strategies: 17% (2 of 12 episodes)
for retention and debridement and 0% (0 of 4 episodes) for
1-stage exchange. One course of suppressive therapy was in
agreement with recommendations. A high number of episodes
(57 episodes; 84%) of PJIs was treated with an adequate or
partially adequate antimicrobial regimen (table 4).
Outcome. Thirty-nine (57%) of 68 patients with PJI had
a successful outcome at 24 months of follow-up. Two patients
with a follow-up time of 21 months were classifie as having
probably been healed. Figure 1A shows the Kaplan-Meier curve
for treatment failure–free survival. The probability of survival
without treatment failure was 54% after 1 year and was 52%
after 2 years. The 29 treatment failures comprised persisting
infection or a new infection in 12 episodes (41%) each; in 5
episodes (17%), death occurred as a consequence of PJI. Success
rates were 50% after retention and debridement, 0% after 1-
stage exchange, and 65% after 2-stage exchange. The healing
rate was 55% (6 episodes) for the 11 streptococcal infections,
100% (2 episodes) for the 2 enterococcal infections, and 53%
(8 episodes) for the 15 PJIs due to a polymicrobial flora
Table 4 summarizes the characteristics of the antimicrobial
treatment administered. When antimicrobial treatment was ad-
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Table 4. Outcome of 68 episodes of prosthetic joint infection
according to antimicrobial treatment.
Variable
No. (%)
of episodes
All infection episodes 68 (100)
Antimicrobial treatmenta
Adequate 32 (47.1)
Partially adequate 25 (36.8)
Inadequate 11 (16.2)
Antimicrobial treatment 90 days 40 (58.8)
Intravenous treatment 14 days 50 (73.5)
Type of oral treatment
Rifampin combination 40 (58.8)
Clindamycin 7 (10.3)
Betalactam 7 (10.3)
Other 6 (8.8)
Intravenous treatment only 6 (8.8)
No antimicrobial treatment 2 (3.0)
a Based on Giulieri et al. [8].
Figure 1. A, Kaplan-Meier curve of the proportion of patients whose
prostheses remained treatment failure–free during follow-up. B, Kaplan-
Meier curve by treatment group ( , by log rank test). Dark blackP ! .001
line, surgical strategy in agreement with recommendation and adequate
or partially adequate antimicrobial treatment; dotted line, surgical strategy
not aligned with recommendations or inadequate antimicrobial treatment;
light black line, surgical strategy in disagreement with recommendations
and inadequate antimicrobial treatment. PJI, prosthetic joint infection.
equate or partially adequate, treatment success rates were 72%
and 56%, respectively. Episodes treated with inadequate anti-
microbial regimens had a very low (18%) success rate.
The success rate was highest (67%; 43 episodes) when the
surgical strategy met current recommendations and antimicro-
bial treatment was adequate or partially adequate ( , byP ! .001
log rank test) (figu e 1B). PJI treated with either a surgical
strategy or an antimicrobial regimen as recommended (np
) still had a success rate of 52%. None of the 6 PJIs treated19
with neither a surgical strategy nor an antimicrobial regimen
meeting recommendations was healed.
Risk factors for treatment failure. Table 5 presents uni-
variate risk factors for treatment failure. Significan risk factors
were the presence of a sinus tract (hazard ratio [HR], 2.3; 95%
CI, 1.1–5.0; ), a high infection score (HR, 1.30; 95%Pp .02
CI, 1.1–1.4; ), a choice of surgical strategy different fromP ! .001
those recommended (HR, 2.3; 95% CI, 1.1–4.7; ) [3],Pp .01
and inadequate antimicrobial treatment (HR, 3.4; 95% CI, 1.5–
7.6; ). In the multivariate Cox regression analysis, thePp .002
following factors were independent risks for therapy failure: a
high infection score (HR, 1.24; 95% CI, 1.10–1.40; ),P ! .001
choice of a surgical treatment strategy in disagreement with
published recommendations (HR, 1.96; 95% CI, ;0.97–3.95
) [3], and an inadequate antimicrobial regimen [5]Pp .05
(HR, 2.79; 95% CI, 1.21–6.45; ).Pp .01
DISCUSSION
This study found that treatment of PJI in accordance with
currently recommended algorithms [3, 11] is associated with
a significantl better outcome, compared with nonrecom-
mended treatment. Both the choice of the surgical strategy and
the antimicrobial treatment played an important role in the
overall treatment success. Two earlier studies reported similar
results, but both studies were conducted at 1 center and in-
cluded a relatively high proportion of PJIs treated with less
invasive surgical strategies. Our study demonstrates the appli-
cability of the recommendations of Zimmerli et al. [3] to a
patient population with relatively high proportions of treatment
failures before referral to our center (41%), polymicrobial in-
fection (22%), episodes involving a sinus tract (21%), and,
consequently, 2-stage exchange procedures (75%).
The mean healing rate of 57% observed in our study was
low in comparison with rates reported by Giulieri et al. (83%)
[8], Trampuz et al. (90%) [13], Tsukayama et al. (91%) [14],
and Meehan et al. (89%) [15]. However, this is likely explained
by different characteristics of PJI episodes. As mentioned above,
our study population included a high proportion of episodes
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Table 5. Univariate analysis of risk factors for treatment failure among 68 patients with prosthetic joint
infection.
Variable
Treatment failure
(n p 29)
Healed
(n p 39) HRa (95% CI) P
Age, mean years  SD 70.6  12.5 64.5  10.4 1.03 (0.99–1.10) .12
Charlson Comorbidity Index, mean score  SD 1.9  2.0 1.4  1.3 1.09 (0.89–1.30) .42
Immunosuppression 4 (13.8) 2 (5.1) 1.87 (0.66–5.30) .24
Duration of symptoms !3 weeks 13 (44.8) 24 (61.5) 1.71 (0.80–3.40) .14
Mean infection score  SD 9.4  2.8 7.1  2.7 1.29 (1.10–1.40) !.001
Sinus tract 10 (34.5) 4 (10.3) 2.35 (1.10–5.0) .02
Inadequate antimicrobial treatment 9 (31.0) 2 (5.1) 3.45 (1.50–7.60) .002
Surgical strategy not as recommendeda 12 (41.4) 8 (20.5) 2.34 (1.10–4.70) .01
NOTE. Data are number (%) of patients, unless otherwise indicated. HR, hazard ratio.
a Based on Giulieri et al. [8].
qualifying for a 2-stage procedure, which indicates more-ad-
vanced disease and/or more–difficult-to-t eat microorganisms.
The healing rate after 2-stage exchange was 90% in the study
by Giulieri et al. [8], 85% in the study by Laffer et al. [9], and
80% in the study by Trampuz et al. [13], compared with 68%
in the present study.
A comparison of this study with other reports [1, 16, 17] is
hampered by the fact that those studies included different pa-
tient populations and/or did not use similar algorithms for the
choice of treatment strategies. Overall treatment success was
56% in a high-risk population with rheumatic disease, of whom
19% were treated with 2-stage exchange and 37% were treated
with resection arthroplasty [16]. However, Marculescu et al.
[17] showed a success rate of 60% with use of debridement
and retention for patients with sinus tract and unstable pros-
thesis. The study by Brandt et al. [1] reported a success rate
of 90% after a 2-stage exchange procedure, but that study was
restricted to PJI due to S. aureus, and early treatment failures
were excluded.
The present study also evaluated risk factors for treatment
failure. Independent risk factors were advanced infection (i.e.,
a high infection score) at start of treatment and lack of ad-
herence to the recommendations of Zimmerli et al. [3] for the
choice of the surgical management and antimicrobial treatment.
Among the studies compared, healing rates were highest for
complete agreement in the present study (67%) and in the
study by Giulieri et al. (88%) [8].
The choice of a surgical strategy in agreement with the al-
gorithm increased healing rates from 40% to 60% in the present
study, from 62% to 88% in the study by Giulieri et al. [8], and
from 86% to 92% in the study by Laffer et al. [9]. The type
of surgical treatment was also the most important predictor of
treatment failure in the study by Berbari et al. [16]. Adherence
to current antimicrobial treatment recommendations increased
success rates from 18% to 65% in the present study, from 50%
to 87% in the study by Giulieri et al. [8], and from 60% to
93%–100% in the report by Laffer et al. [9]. In our study, the
assessment that there was a lack of adequate antimicrobial treat-
ment was often because the duration of treatment was shorter
than recommended. Compliance with long-term therapy after
hospital discharge is often difficul to control and poses a chal-
lenge to improvement strategies. Overall, our study demon-
strates the value of current surgical and antimicrobial treatment
recommendations in an expanded patient population.
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